Orphans Wanted: FDA Offers New Ideas For Rare Disease Drug Development
Executive Summary
FDA's top review managers have a message for drug developers: they are eager to find creative ways to work with sponsors to bring new treatments for rare diseases to market
You may also be interested in...
Orphan, Tropical Diseases Need Better Drug Development Guidance - Senate
A floor amendment to the Senate Agriculture/FDA appropriations bill would push FDA toward streamlining the development and regulation of drugs to treat rare diseases and neglected diseases in the developing world
Orphan, Tropical Diseases Need Better Drug Development Guidance - Senate
A floor amendment to the Senate Agriculture/FDA appropriations bill would push FDA toward streamlining the development and regulation of drugs to treat rare diseases and neglected diseases in the developing world
NIH Director Nominee Collins May Push Translational Medicine Into Spotlight
Francis Collins' intellectual agility and experience working on huge initiatives with a lot of moving parts - the human genome project comes to mind - will serve him well as the National Institutes of Health's director